DiviDrip · PMCB

PMCB — PharmaCyte Biotech, Inc.

PMCB is PharmaCyte Biotech, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.48. Market cap: $5M. Capital Quality Rank: 19/100 — Capital destroyer.

Stock snapshot

Price$0.48
Market cap$5M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)19 / 100 · Capital destroyer
ROIC (TTM)-33.9%
Shareholder buyback yield-12.52%
Altman Z-score zoneDistress

About PMCB

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Listed2003Employees2HQLas Vegas, NVSectorHealthcareWebsitepharmacyte.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PMCB. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PMCB's current stock price?

PMCB (PharmaCyte Biotech, Inc.) is currently trading at $0.48.

Does PMCB pay a dividend?

PMCB (PharmaCyte Biotech, Inc.) does not currently pay a regular dividend.

What is PMCB's Capital Quality Rank?

PMCB has a Capital Quality Rank of 19/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PMCB in DiviDrip

Add PMCB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow